Cruciate Ligament Diagnosis and Treatment Market Research Report – Forecast to 2027

Cruciate Ligament Diagnosis & treatment Market Research Report: Injury Type (Grade I, II, III), Product (Cement Implants, Cement-Less Implants), Indication (Osteoarthritis, RA), Treatment (Surgery), End-User (Hospitals, ASCs) – Global Forecast Till 2027

ID: MRFR/Pharma/4622-HCR | February 2021 | Region: Global | 100 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


The global cruciate ligament diagnosis and treatment market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the cruciate ligament diagnosis and treatment market is expected to register a CAGR of 6.4% during the forecast period of 2018–2023.


A ligament is a band of tissue that holds the bones together, keeping the knee stable. Primarily these ligaments are broadly classified into cruciate ligament and collateral ligament. Further, these are divided into four primary ligaments, namely, Anterior Cruciate Ligament (ACL), Posterior Cruciate Ligament (PCL), Medial Collateral Ligament (MCL), and Lateral Collateral Ligament (LCL). The cruciate ligaments, i.e., the PCL and ACL are crossed ligaments that stabilize the joint while allowing a very large range of motion. Knee injuries are usually the most common musculoskeletal traumas among people, where the Anterior Cruciate Ligament (ACL) injury is one of the utmost frequent occurring knee injuries. Surgical reconstruction is the standard gold treatment for treating knee injuries. Increasing incidences of sports-related injuries have become a leading cause of soft tissue injuries worldwide. Athletes are most likely to injure the ACLs disabling complete stretching of their legs.   A type of surgery that involves reconstruction of the ligament is known as ACL reconstruction that lies in the center of one’s knee with a graft. As per an article published in PubMed (2017), approximately 200,000 ACL injuries are registered each year on an average in the U.S. Cruciate ligaments repair is also the fastest growing segment for the soft tissue repair market globally. Subsequently, it is most commonly treated upon the athletes as they are mostly affected by ACL injuries owing to sport-related activities.

Numerous other factors such as growing number of knee reconstruction surgeries, increase in aging population coupled with rising incidences of diseases related to age such as rheumatoid arthritis and osteoarthritis, and increasing government assistance are continuously contributing to the growth of the global cruciate ligament diagnosis and treatment market.


Despite these drivers, there are some issues associated with the cruciate ligament diagnosis and treatment market. The complications associated with the treatment, lack of skilled or trained physicians, and poor healthcare system in low and middle-income countries may hamper the growth of the market.


Research Methodology


Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, treatment assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments & categories geographically presented are studied and are estimated based on primary & secondary research.



  • Primary Research


The extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.



  • Secondary Research


Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the cruciate ligament diagnosis and treatment market. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, & developments related to the market and treatment perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, the international organization of chemical manufacturers, some paid databases and many others.


Key Players


Some of the key players in the global cruciate ligament diagnosis & treatment market are Stryker Corporation (U.S.), Arthrex, Inc. (U.S.), Zimmer Biomet (U.S.), DePuy Synthes, Inc. (U.S.), CONMED Corporation (U.S.), Smith & Nephew plc. (U.S.), DJO Global Inc. (U.S.), Breg, Inc. (U.S.), Bauerfeind AG (Germany), Össur hf. (Iceland), BSN Medical GmbH (Germany), 3M Company (U.S.), Otto Bock Healthcare GmbH (Germany), THUASNE SA (France), medi GmbH & Co. KG (Germany), DeRoyal Industries Inc. (U.S.), Corin Group (UK), United Orthopedic Corporation (Taiwan), Exactech Inc. (U.S.), Japan Medical Dynamic Marketing (Japan), Tornier Inc. (U.S.), and others.


Segmentation


The global cruciate ligament diagnosis and treatment market is segmented on the basis of type, injury type, product, diagnosis, treatment, and end-user.


Based on type, the global cruciate ligament diagnosis and treatment market is classified as Posterior Cruciate Ligament (PCL) and Anterior Cruciate Ligament (ACL).


The segments for injury type for the global cruciate ligament diagnosis and treatment market are classified as grade I, grade II, and grade III.


On the basis of product, the global cruciate ligament diagnosis and treatment market is classified as cemented implants, cement-less implants, partial implants, and revision implants.


Based on indication, the global cruciate ligament diagnosis and treatment market is classified as osteoarthritis, rheumatoid arthritis, trauma, and others.


The diagnosis segment for the global cruciate ligament diagnosis and treatment market is classified as imaging others. The imaging segment is further classified as Magnetic Resonance Imaging (MRI), ultrasound, laparoscopy, and others.


Based on treatment, the global cruciate ligament diagnosis and treatment market is classified as surgery, therapies, devices, and others. Surgery can be further sub-divided into arthroscopy, Anterior Cruciate Ligament (ACL) reconstruction, and others. The therapies include rehabilitation and physical therapies. The devices include elastic bandages and others.


On the basis of end-user, the global cruciate ligament diagnosis and treatment market is classified as hospitals, orthopedic clinics, Ambulatory Surgical Centers (ASC), and others.


Geographically, the global cruciate ligament diagnosis and treatment market has been segmented into America, Europe, Asia Pacific, and the Middle East and Africa. The American cruciate ligament diagnosis and treatment market is further segmented into North America and South America. North America is further classified as the U.S. and Canada.


The European cruciate ligament diagnosis and treatment market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the U.K., Italy, Spain, and the Rest of Western Europe.


The Asia Pacific cruciate ligament diagnosis and treatment market is segmented into Japan, China, India, Republic of Korea, Australia, and the Rest of Asia Pacific.


The Middle Eastern and African cruciate ligament diagnosis and treatment market is segmented into the Middle East and Africa.


Regional Market Summary


Global Cruciate Ligament Diagnosis & Treatment Market, by Region Market Share, 2017 (%)


 Cruciate Ligament Diagnosis & Treatment Market


Source: MRFR Analysis


The Americas dominates the cruciate ligament diagnosis and treatment market owing to the rising prevalence of osteoarthritis among the elderly population, well-developed surgical technology, high healthcare expenditure, and the presence of the leading players.


This market is attracting many key participants such as Stryker Corporation; Zimmer Biomet; DePuySynthes, Inc., Arthrex, Inc.; Smith & Nephew plc; and CONMED Corporation. For instance, Smith & Nephew acquired the diversified product portfolio for orthopedic soft tissue repair from ArthroCare Corporation further strengthening the position of the company in the global market.


Europe holds the second position in the cruciate ligament diagnosis and treatment market. It is expected that the rising contribution towards research and development for the development of surgical implants and increasing competition among marketers for drug launch are likely to drive the European cruciate ligament diagnosis and treatment market. For instance, in May 2017 Ablynx, a biopharmaceutical company headquartered in Belgium, announced the completion of a preclinical package for a novel nanobody, ALX-1141 for the treatment of osteoarthritis. Merck will now be responsible for the further clinical development of the molecule.


Asia Pacific is the fastest growing cruciate ligament diagnosis and treatment market owing to a huge patient pool, increasing demand for treatments, and rising healthcare expenditure. For instance, in July 2017, Kolon Pharmaceutical got the approval for the World's first cell and gene therapy for knee osteoarthritis in Korea. Thus, all these factors are cumulatively responsible for the growth in this region.


The Middle East and Africa holds the lowest share of the global cruciate ligament diagnosis and treatment market due to low development, lack of technical knowledge, and poor medical facilities.


Global Cruciate Ligament Diagnosis & Treatment Market, by type



  • Posterior Cruciate Ligament (PCL)

  • Anterior Cruciate Ligament (ACL)


Global Cruciate Ligament Diagnosis & Treatment Market, by Injury type



  • Grade I

  • Grade II

  • Grade III.


Global Cruciate Ligament Diagnosis & Treatment Market, by Indication



  • Osteoarthritis

  • Rheumatoid arthritis

  • Trauma


Global Cruciate Ligament Diagnosis & Treatment Market, by Product



  • Cemented implants

  • Cement-less implants

  • Partial implants

  • Revision implants.


Global Cruciate Ligament Diagnosis & Treatment Market, by Diagnosis



  • Imaging

  • Magnetic Resonance Imaging (MRI)’

  • Ultrasound

  • Laparoscopy

  • Others


Global Cruciate Ligament Diagnosis & Treatment Market, by Treatment



  • Surgery

  • Arthroscopy

  • Anterior Cruciate Ligament (ACL) reconstruction

  • Others

  • Therapies

  • Rehabilitation

  • Physical Therapies

  • Devices

  • Elastic Bandages

  • Others


Global Cruciate Ligament Diagnosis & Treatment Market, by End-user



  • Hospitals

  • Orthopedic Clinics

  • Ambulatory Surgical Center (ASC)


Global Cruciate Ligament Diagnosis & Treatment Market, by Region



  • Americas

    • North America

      • U.S.

      • Canada



    • South America



  • Europe

    • Western Europe

    • Germany

    • France

    • Italy

    • Spain

    • U.K.

    • Rest of Western Europe

    • Eastern Europe



  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Republic of Korea

    • Rest of Asia Pacific



  • The Middle East & Africa

    • Middle East

    • Africa




Company Profiles    



  • Stryker Corporation

  • Arthrex, Inc.

  • Zimmer Biomet

  • DePuy Synthes, Inc.

  • CONMED Corporation

  • Smith & Nephew plc.

  • DJO Global Inc.

  • Breg, Inc.

  • Bauerfeind AG



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   6.4% (2018-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Injury type, Product, Diagnosis, Treatment, and End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Stryker Corporation (U.S.), Arthrex, Inc. (U.S.), Zimmer Biomet (U.S.), DePuy Synthes, Inc. (U.S.), CONMED Corporation (U.S.), Smith & Nephew plc. (U.S.), DJO Global Inc. (U.S.), Breg, Inc. (U.S.), Bauerfeind AG (Germany), Össur hf. (Iceland), BSN Medical GmbH (Germany), 3M Company (U.S.), Otto Bock Healthcare GmbH (Germany), THUASNE SA (France), medi GmbH & Co. KG (Germany), DeRoyal Industries Inc. (U.S.), Corin Group (UK), United Orthopedic Corporation (Taiwan), Exactech Inc. (U.S.), Japan Medical Dynamic Marketing (Japan), Tornier Inc. (U.S.), and others
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Growing number of knee reconstruction surgeries
  • Increase in aging population
  • Rising incidences of diseases
  • Increasing Government assistance


  • Frequently Asked Questions (FAQ) :


    Major products used in cruciate ligament diagnosis and treatment include cemented implants, cement-less implants, partial implants, and revision implants.

    Global cruciate ligament diagnosis and treatment market is expected to exhibit a strong 6.4% CAGR over the forecast period from 2020to 2027.

    The growing prevalence of sports-related cruciate ligament injuries is the major driver for the cruciate ligament diagnosis and treatment market.

    The Americas dominate the global cruciate ligament diagnosis and treatment market.

    Leading players in the cruciate ligament diagnosis and treatment market include Breg Inc., Stryker, and Arthrex, among others.

    Table of Content

    1. Report Prologue

    2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    6. Global Cruciate Ligament Diagnosis and Treatment Market, by Type

    6.1 Introduction

    6.2 Posterior Cruciate Ligament (PCL)

    Market Estimates & Forecast, 2020–2027

    Market Estimates & Forecast, by Region/Country, 2020–2027

    6.3 Anterior Cruciate Ligament (ACL)

    Market Estimates & Forecast, 2020–2027

    Market Estimates & Forecast, by Region/Country, 2020–2027

    6.3.1 Clinical

    6.3.2 Non-Clinical

    7. Global Cruciate Ligament Diagnosis and Treatment Market, by Injury Type

    7.1 Introduction

    7.2 Grade I

    Market Estimates & Forecast, 2020–2027

    Market Estimates & Forecast, by Region/Country, 2020–2027

    7.3 Grade II

    Market Estimates & Forecast, 2020–2027

    Market Estimates & Forecast, by Region/Country, 2020–2027

    7.4 Grade III

    Market Estimates & Forecast, 2020–2027

    Market Estimates & Forecast, by Region/Country, 2020–2027

    8. Global Cruciate Ligament Diagnosis and Treatment Market, by Indication

    8.1 Introduction

    8.2 Osteoarthritis

    Market Estimates & Forecast, 2020–2027

    Market Estimates & Forecast, by Region/Country, 2020–2027

    8.3 Rheumatoid Arthritis

    Market Estimates & Forecast, 2020–2027

    Market Estimates & Forecast, by Region/Country, 2020–2027

    8.4 Trauma

    Market Estimates & Forecast, 2020–2027

    Market Estimates & Forecast, by Region/Country, 2020–2027

    8.5 Others

    Market Estimates & Forecast, 2020–2027

    Market Estimates & Forecast, by Region/Country, 2020–2027

    9. Global Cruciate Ligament Diagnosis and Treatment Market, by Product

    9.1 Introduction

    9.2 Cemented implants

    Market Estimates & Forecast, 2020–2027

    Market Estimates & Forecast, by Region/Country, 2020–2027

    9.3 Cement-less implants

    Market Estimates & Forecast, 2020–2027

    Market Estimates & Forecast, by Region/Country, 2020–2027

    9.4 Partial Implants

    Market Estimates & Forecast, 2020–2027

    Market Estimates & Forecast, by Region/Country, 2020–2027

    9.5 Revision Implants

    Market Estimates & Forecast, 2020–2027

    Market Estimates & Forecast, by Region/Country, 2020–2027

    10. Global Cruciate Ligament Diagnosis and Treatment Market, by Diagnosis

    10.1 Introduction

    10.2 Imaging

    Market Estimates & Forecast, 2020–2027

    Market Estimates & Forecast, by Region/Country, 2020–2027

    10.2.1 Magnetic Resonance Imaging (MRI)

    10.2.2 Ultrasound

    10.2.3 Laparoscopy

    10.2.4 Others

    10.3 Others

    Market Estimates & Forecast, 2020–2027

    Market Estimates & Forecast, by Region/Country, 2020–2027

    11. Global Cruciate Ligament Diagnosis and Treatment Market, by Treatment

    11.1 Introduction

    11.2 Surgery

    Market Estimates & Forecast, 2020–2027

    Market Estimates & Forecast, by Region/Country, 2020–2027

    11.2.1 Arthroscopy

    11.2.2 Anterior Cruciate Ligament (ACL) reconstruction

    11.2.3 Others

    11.3 Therapies

    Market Estimates & Forecast, 2020–2027

    Market Estimates & Forecast, by Region/Country, 2020–2027

    11.3.1 Rehabilitation’

    11.3.2 Physical Therapies

    11.4 Devices

    Market Estimates & Forecast, 2020–2027

    Market Estimates & Forecast, by Region/Country, 2020–2027

    11.3.1 Elastic Bandages

    11.3.2 Others

    11.5 Others

    Market Estimates & Forecast, 2020–2027

    Market Estimates & Forecast, by Region/Country, 2020–2027

    12. Global Cruciate Ligament Diagnosis and Treatment Market, by End-User

    9.1 Introduction

    12.2 Hospitals

    Market Estimates & Forecast, 2020–2027

    Market Estimates & Forecast, by Region/Country, 2020–2027

    12.3 Orthopedic Clinics

    Market Estimates & Forecast, 2020–2027

    Market Estimates & Forecast, by Region/Country, 2020–2027

    12.4 Ambulatory Surgical Center (ASC)

    Market Estimates & Forecast, 2020–2027

    Market Estimates & Forecast, by Region/Country, 2020–2027

    13 Global Cruciate Ligament Diagnosis and Treatment Market, by Region

    13.1 Introduction

    13.2 Americas

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.2.1 North America

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.2.1.1 U.S.

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.2.1.2 Canada

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.2.2 South America

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.3 Europe

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.3.1 Western Europe

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.3.1.1 Germany

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.3.1.2 France

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.3.1.3 U.K.

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.3.1.4 Italy

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.3.1.5 Spain

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.3.1.6 Rest of Western Europe

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.3.2 Eastern Europe

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.4 Asia Pacific

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.4.1 Japan

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.4.2 China

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.4.3 India

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.4.4 Australia

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.4.5 Republic of Korea

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.4.6 Rest of Asia Pacific

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.5 The Middle East & Africa

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.5.1 The Middle East

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    13.5.2 Africa

    • Market Estimates & Forecast, by Region, 2020–2027

    • Market Estimates & Forecast, by Type, 2020–2027

    • Market Estimates & Forecast, by Injury type, 2020–2027

    • Market Estimates & Forecast, by Indication, 2020–2027

    • Market Estimates & Forecast, by Diagnosis, 2020–2027

    • Market Estimates & Forecast, by Treatment, 2020–2027

    • Market Estimates & Forecast, by End-User, 2020–2027

    14 Company Landscape

    14.1 Introduction

    14.2 Market Share Analysis

    14.3 Key Development & Strategies

    14.3.1 Key Developments

    15 Company Profiles

    15.1 Stryker Corporation

    15.1.1 Company Overview

    15.1.2 Type Overview

    15.1.3 Financials

    15.1.4 SWOT Analysis

    15.2 Arthrex, Inc.

    15.2.1 Company Overview

    15.2.2 Product Overview

    15.2.3 Financial Overview

    15.2.4 Key Developments

    15.2.5 SWOT Analysis

    15.3 Zimmer Biomet

    15.3.1 Company Overview

    15.3.2 Type Overview

    15.3.3 Financial Overview

    15.3.4 Key Development

    15.3.5 SWOT Analysis

    15.4 DePuy Synthes, Inc.

    15.4.1 Company Overview

    15.4.2 Type/Business Segment Overview

    15.4.3 Financial Overview

    15.4.4 Key Development

    15.4.5 SWOT Analysis

    15.5 CONMED Corporation

    15.5.1 Company Overview

    15.5.2 Type Overview

    15.5.3 Financial overview

    15.5.4 Key Developments

    15.6 Smith & Nephew plc.

    15.6.1 Company Overview

    15.6.2 Type Overview

    15.6.3 Financial Overview

    15.6.4 Key Developments

    15.7 DJO Global Inc.

    15.7.1 Overview

    15.7.2 Type Overview

    15.7.3 Financials

    15.7.4 Key Developments

    15.7.5 SWOT Analysis

    15.8 Breg, Inc.

    15.8.1 Overview

    15.8.2 Type Overview

    15.8.3 Financials

    15.8.4 Key Developments

    15.8.5 SWOT Analysis

    15.9 Bauerfeind AG

    15.9.1 Overview

    15.9.2 Type Overview

    15.9.3 Financials

    15.9.4 Key Developments

    15.9.5 SWOT Analysis

    15.10 Össur hf.

    15.10.1 Overview

    15.10.2 Type Overview

    15.10.3 Financials

    15.10.4 Key Developments

    15.10.5 SWOT Analysis

    15.11 DeRoyal Industries, Inc.

    15.11.1 Overview

    15.11.2 Type Overview

    15.11.3 Financials

    15.11.4 Key Developments

    15.11.5 SWOT Analysis

    15.12 BSN Medical GmbH

    15.15.1 Overview

    15.15.2 Type Overview

    15.15.3 Financials

    15.15.4 Key Developments

    15.15.5 SWOT Analysis

    15.13 3M Company

    15.13.1 Overview

    15.13.2 Type Overview

    15.13.3 Financials

    15.13.4 Key Developments

    15.13.5 SWOT Analysis

    16 Appendix


    LIST OF TABLES

    Table 1 Cruciate Ligament Diagnosis and Treatment Industry Synopsis, 2020–2027

    Table 2 Global Cruciate Ligament Diagnosis and Treatment Market Estimates and Forecast, 2020–2027, (USD Million)

    Table 3 Global Cruciate Ligament Diagnosis and Treatment Market, by Region, 2020–2027, (USD Million)

    Table 5 Global Cruciate Ligament Diagnosis and Treatment Market, by Type, 2020–2027, (USD Million)

    Table 5 Global Cruciate Ligament Diagnosis and Treatment Market, by Injury type, 2020–2027, (USD Million)

    Table 6 Global Cruciate Ligament Diagnosis and Treatment Market, by Indication, 2020–2027, (USD Million)

    Table 7 Global Cruciate Ligament Diagnosis and Treatment Market, by End-User, 2020–2027, (USD Million)

    Table 8 North America Cruciate Ligament Diagnosis and Treatment Market, by Type, 2020–2027, (USD Million)

    Table 9 North America Cruciate Ligament Diagnosis and Treatment Market, by Indication, 2020–2027, (USD Million)

    Table 9 North America Cruciate Ligament Diagnosis and Treatment Market, by Injury type, 2020–2027, (USD Million)

    Table 10 North America Cruciate Ligament Diagnosis and Treatment Market, by End-User, 2020–2027, (USD Million)

    Table 11 U.S. Cruciate Ligament Diagnosis and Treatment Market, by Type, 2020–2027, (USD Million)

    Table 12 U.S. Cruciate Ligament Diagnosis and Treatment Market, by Indication, 2020–2027, (USD Million)

    Table 12 U.S. Cruciate Ligament Diagnosis and Treatment Market, by Injury type, 2020–2027, (USD Million)

    Table 13 U.S. Cruciate Ligament Diagnosis and Treatment Market, by End-User, 2020–2027, (USD Million)

    Table 14 Canada Cruciate Ligament Diagnosis and Treatment Market, by Type, 2020–2027, (USD Million)

    Table 14 Canada Cruciate Ligament Diagnosis and Treatment Market, by Injury type, 2020–2027, (USD Million)

    Table 15 Canada Cruciate Ligament Diagnosis and Treatment Market, by Indication, 2020–2027, (USD Million)

    Table 16 Canada Cruciate Ligament Diagnosis and Treatment Market, by End-User, 2020–2027, (USD Million)

    Table 17 South America Cruciate Ligament Diagnosis and Treatment Market, by Type, 2020–2027, (USD Million)

    Table 18 South America Cruciate Ligament Diagnosis and Treatment Market, by Indication, 2020–2027, (USD Million)

    Table 19 South America Cruciate Ligament Diagnosis and Treatment Market, by End-User, 2020–2027, (USD Million)

    Table 20 Europe Cruciate Ligament Diagnosis and Treatment Market, by Type, 2020–2027, (USD Million)

    Table 21 Europe Cruciate Ligament Diagnosis and Treatment Market, by Indication, 2020–2027, (USD Million)

    Table 22 Europe Cruciate Ligament Diagnosis and Treatment Market, by End-User, 2020–2027, (USD Million)

    Table 23 Western Europe Cruciate Ligament Diagnosis and Treatment Market, by Type, 2020–2027, (USD Million)

    Table 24 Western Europe Cruciate Ligament Diagnosis and Treatment Market, by Indication, 2020–2027, (USD Million)

    Table 25 Western Europe Cruciate Ligament Diagnosis and Treatment Market, by End-User, 2020–2027, (USD Million)

    Table 26 Eastern Europe Cruciate Ligament Diagnosis and Treatment Market, by Type, 2020–2027, (USD Million)

    Table 27 Eastern Europe Cruciate Ligament Diagnosis and Treatment Market, by Indication, 2020–2027, (USD Million)

    Table 28 Eastern Europe Cruciate Ligament Diagnosis and Treatment Market, by End-User, 2020–2027, (USD Million)

    Table 29 Asia Pacific Cruciate Ligament Diagnosis and Treatment Market, by Type, 2020–2027, (USD Million)

    Table 30 Asia Pacific Cruciate Ligament Diagnosis and Treatment Market, by Indication, 2020–2027, (USD Million)

    Table 31 Asia Pacific Cruciate Ligament Diagnosis and Treatment Market, by End-User, 2020–2027, (USD Million)

    Table 32 Middle East & Africa Cruciate Ligament Diagnosis and Treatment Market, by Type, 2020–2027, (USD Million)

    Table 33 Middle East & Africa Cruciate Ligament Diagnosis and Treatment Market, by Injury type, 2020–2027, (USD Million)

    Table 34 Middle East & Africa Cruciate Ligament Diagnosis and Treatment Market, by End-User, 2020–2027, (USD Million)


    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Cruciate Ligament Diagnosis and Treatment Market

    Figure 3 Segmentation Market Dynamics for Cruciate Ligament Diagnosis and Treatment Market

    Figure 4 Global Cruciate Ligament Diagnosis and Treatment Market Share, by Type 2020

    Figure 5 Global Cruciate Ligament Diagnosis and Treatment Market Share, by Injury type 2020

    Figure 6 Global Cruciate Ligament Diagnosis and Treatment Market Share, by End-User, 2020

    Figure 7 Global Cruciate Ligament Diagnosis and Treatment Market Share, by Region, 2020

    Figure 8 North America Cruciate Ligament Diagnosis and Treatment Market Share, by Country, 2020

    Figure 9 Europe Cruciate Ligament Diagnosis and Treatment Market Share, by Country, 2020

    Figure 10 Asia Pacific Cruciate Ligament Diagnosis and Treatment Market Share, by Country, 2020

    Figure 11 Middle East & Africa Cruciate Ligament Diagnosis and Treatment Market Share, by Country, 2020

    Figure 12 Global Cruciate Ligament Diagnosis and Treatment Market: Company Share Analysis, 2020 (%)

    Figure 13 Stryker Corporation: Key Financials

    Figure 14 Stryker Corporation: Segmental Revenue

    Figure 16 Stryker Corporation: Geographical Revenue

    Figure 17 Zimmer Biomet. Key Financials

    Figure 18 Zimmer Biomet: Segmental Revenue

    Figure 19 Zimmer Biomet: Geographical Revenue

    Figure 20 Ortho Clinical Diagnostics: Key Financials

    Figure 21 Ortho Clinical Diagnostics: Segmental Revenue

    Figure 22 Ortho Clinical Diagnostics: Geographical Revenue

    Figure 23 DePuy Synthes, Inc.: Key Financials

    Figure 24 DePuy Synthes, Inc.: Segmental Revenue

    Figure 25 DePuy Synthes, Inc.: Geographical Revenue

    Figure 26 Smith & Nephew plc.: Key Financials

    Figure 27 Smith & Nephew plc.: Segmental Revenue

    Figure 28 Smith & Nephew plc. Geographical Revenue

    Figure 29 Arthrex, Inc. Key Financials

    Figure 30 Arthrex, Inc. Segmental Revenue

    Figure 31 Arthrex, Inc. Geographical Revenue